For the Inventor, By the Inventor

Enter assignee name

Slough, United Kingdom

Lonza Biologics Plc

USPTO Granted Patents = 25

CIPO Patents = 4

EPO Patents = 17

Forward Citations = 60

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

Robert Young (7 out of 8 patents)

James Rance (4 out of 4 patents)

Mohsan Waseem Khan (3 out of 8 patents)

4. Marc Feary (3 out of 4 patents)

5. Jesus Zurdo (3 out of 8 patents)

6. Michael J Agostino (2 out of 11 patents)

7. Lin Zhang (2 out of 2 patents)

8. Baohong Zhang (2 out of 2 patents)

9. Christopher M Smales (2 out of 2 patents)

10. Tom Payne (2 out of 4 patents)

11. Mark R Whickman (2 out of 2 patents)

12. Sam Mansoor (2 out of 2 patents)

13. Johan Desmet (2 out of 9 patents)

14. Ignace Lasters (2 out of 16 patents)

15. Andreas Arnell (2 out of 2 patents)

25 patents: Sort by Forward Citations

1. 12092483 - Sensor shield (2024-09-17),

2. 11767537 - Mammalian expression system (2023-09-26),

3. 11326185 - Site-specific integration (2022-05-10),

4. 10669541 - Means and methods for the generation of mammalian producer cells for the production of recombinant proteins (2020-06-02),

5. 10294491 - Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences (2019-05-21),

6. 10280436 - Site-specific integration (2019-05-07),

7. 10221209 - Method and system for polypeptide purification (2019-03-05),

8. 10179898 - Bioreactor for the cultivation of mammalian cells (2019-01-15),

9. 10139418 - Rapid method for targeted cell (line) selection (2018-11-27),

10. 9783771 - Three bioreactor system for the cultivation of mammalian cells (2017-10-10),

11. 9783770 - Deepwell plate system with lid (2017-10-10),

12. 9777290 - Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences (2017-10-03),

13. 9670446 - Bioreactor for the cultivation of mammalian cells (2017-06-06),

14. 9290563 - Variant immunoglobulins with improved manufacturability (2016-03-22),

15. 8951516 - Variant immunoglobulins with improved manufacturability (2015-02-10),

Lonza Biologics PLC is a global company in the life sciences sector, specializing in the development and manufacturing of biotech and pharmaceutical products. With a strong focus on innovation, Lonza offers a wide range of services to support the entire product life cycle, from early stage development to commercial manufacturing. Their capabilities include cell line construction, process development, and large-scale production. Lonza Biologics PLC is committed to delivering high-quality solutions to enhance global health and improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

25 Patents

#6 in Slough

#701 in United Kingdom

#24,954 in the World

Slough, United Kingdom

Lonza Biologics Plc

Forward Citations = 60

55 inventors:

Robert Young (7 out of 8 patents)

James Rance (4 out of 4 patents)

Mohsan Waseem Khan (3 out of 8 patents)

4. Marc Feary (3 out of 4 patents)

5. Jesus Zurdo (3 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…